Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BioCardia Q2 2024 GAAP EPS $(0.88), Sales $3.000K Miss $50.000K Estimate

Author: Benzinga Newsdesk | August 13, 2024 04:05pm
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.88) per share. The company reported quarterly sales of $3.000 thousand which missed the analyst consensus estimate of $50.000 thousand by 94.00 percent. This is a 93.02 percent decrease over sales of $43.000 thousand the same period last year.

Posted In: BCDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist